offline
Thermo Fisher (TMO) Q2 Earnings Beat on COVID-19-Led Sales
Thermo Fisher Scientific Inc.'s TMO second-quarter 2020 adjusted earnings per share of $3.89 beat the Zacks Consensus Estimate by 45.7%. The figure improved 27.9% year over year. The adjusted number excludes certain non-recurring expenses including, asset amortization costs and certain restructuring costs.
On a reported basis, earnings per share were $2.90, up 4.7% year over year.
Revenues in the quarter under review grossed $6.92 billion, up 9.5% year over year. The top line edged past the Zacks Consensus Estimate by 0.1%.
...
https://finance.yahoo.com/news/thermo-fi...02270.html
![[Bild: TMOc1dl0439.png]](https://finviz.com/publish/072320/TMOc1dl0439.png)
Thermo Fisher Scientific Inc.'s TMO second-quarter 2020 adjusted earnings per share of $3.89 beat the Zacks Consensus Estimate by 45.7%. The figure improved 27.9% year over year. The adjusted number excludes certain non-recurring expenses including, asset amortization costs and certain restructuring costs.
On a reported basis, earnings per share were $2.90, up 4.7% year over year.
Revenues in the quarter under review grossed $6.92 billion, up 9.5% year over year. The top line edged past the Zacks Consensus Estimate by 0.1%.
...
https://finance.yahoo.com/news/thermo-fi...02270.html
__________________
